1. Ovarian cancer detection combining an innovative catheter for uterine and tubal lavage with ultra-sensitive TP53 sequencing. (1st November 2019) Authors: Speiser, P; Maritschnegg, E; Heitz, F; Pecha, N; Bouda, J; Trillsch, F; Grimm, C; Vanderstichele, A; Agreiter, C; Harter, P; Obermayr, E; Vergote, I; Zeillinger, R; Salk, JJ; Risques, RA; Austria, AGO Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TP53 mutations in cell-free DNA as early markers of therapeutic response in platinum-resistant relapsed ovarian cancer (PROC): a prospective translational analysis of the phase II GANNET53 clinical trial. (1st November 2019) Authors: Vanderstichele, A; Concin, N; Busschaert, P; Braicu, I; Combe, P; Ray-Coquard, I; Joly, F; Harter, P; Wimberger, P; Selle, F; Ignatov, A; Schmalfeldt, B; Van Nieuwenhuysen, E; Darb-Esfahani, S; Zeimet, A; Mahner, S; Pujade-Lauraine, E; Marth, C; Berger, R; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗